Effect of Orthosiphon stamineus plant extract on in vitro dermal papilla cell proliferation and ex vivo hair growth
Keywords:
Hair growth, Orthosiphon stamineus extract, Java tea, dermal papilla cellAbstract
Background : The study of Orthosiphon stamineus (OSE) on hair growth is still limited. The potential use of OSE as hair growth promotion in both human dermal papilla cells and androgenic alopecia (AGA) patient hair follicle model may be used to develop a novel hair promoting products derived from Thai natural resources.
Objective : The objective of this study was to investigate the effect of Orthosiphon stamineus plant extract on in vitro dermal papilla cell proliferation and ex vivo hair growth.
Methods : Dermal papilla cell lines were cultured with medium and OSE at concentration 25 - 250 μg/mL for 24 hr for acute cytotoxicity evaluation and 5 days to detect proliferation. In ex vivo hair follicle culture, 45 hair samples from three AGA patients were cultured for 14 days in medium and OSE at 125, 250,500 μg/mL. Hair length was measured every two days and the results were compared with vehicle treated control and positive control.
Results : OSE at concentration 25 - 250 μg/mL showed no acute cytotoxicity to cell after 24 hours culture. Furthermore, OSE at all concentrations could stimulate dermal papilla cell proliferation when cultured for 5 days, (P <0.05). Also, OSE at 500 μg/mL could enhance hair follicles of androgenic alopecia patients in vitro by 12% after 14 days of culturing which were more than vehicle (6.46%) (P <0.05). And based on area under the curve from day 0 – day 14, OSE at 500 μg/mL could enhance total hair growth significantly at 217% (P <0.05), compared to vehicle but OSE at lower concentration and positive control were not significantly different from vehicle.
Conclusion : OSE could significantly stimulate growth of human hair follicle of AGA patients ex vivo and promoted proliferation of the dermal papilla cells compared to vehicle treated control.
Downloads
References
Akowuah GA, Zhari I, Norhayati I, Sadikun A, Khamsah SM. Sinensetin, eupatorin, 32 - hydroxy-5, 6, 7, 42 -tetramethoxyflavone and rosmarinic acid contents and antioxidative effect ofOrthosiphonstamineusfrom Malaysia. Food Chem 2004;87:559-66.
https://doi.org/10.1016/j.foodchem.2004.01.008
Jain R, De Eknamkul W. Potential targets in the discovery of new hair growth promoters for androgenic alopecia. Expert Opin Ther Targets 2014;18:787-806. https://doi.org/10.1517/14728222.2014.922956
Vogelgesang B, Abdul-Malak N, Reymermier C, Altobelli C, Saget J. On the effects of a plant extract of Orthosiphonstamineus on sebumrelated skin imperfections. Int J Cosmet Sci 2011;33:44-52.
https://doi.org/10.1111/j.1468-2494.2010.00581.x
Kiratipaiboon C, Tengamnuay P, Chanvorachote P. Ciprofloxacin improves the stemness of human dermal papilla cells. Stem Cells Int 2016;2016:5831276. https://doi.org/10.1155/2016/5831276
Jain R, Monthakantirat O, Tengamnuay P, De Eknamkul W. Avicequinone C isolated from Avicennia marina exhibits 5alpha-reductasetype 1 inhibitory activity using an androgenic alopecia relevant cell-based assay system. Molecules 2014;19:6809-21. https://doi.org/10.3390/molecules19056809
Kwon OS, Han JH, Yoo HG, Chung JH, Cho KH, Eun HC, et al. Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG). Phytomedicine 2007;14:551-5.
https://doi.org/10.1016/j.phymed.2006.09.009
Philpott MP, Sanders DA, Kealey T. Whole hair follicle culture. Dermatol Clin 1996;14:595-607.
https://doi.org/10.1016/S0733-8635(05)70387-9
Westgate GE, Gibson WT, Kealey T, Philpott MP. Prolonged maintenance of human hair follicles in vitro in a serum-free medium. Br J Dermatol 1993;129:372-9. https://doi.org/10.1111/j.1365-2133.1993.tb03160.x
Messenger AG. The control of hair growth: an overview. J Invest Dermatol 1993;101:4S-9S.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Chulalongkorn Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.